Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Vissaria Sakka"'
Autor:
Ioannis Grigoropoulos, Georgios Tsioulos, Artemis Kastrissianakis, Shiran Shapira, Orr Green, Vasiliki Rapti, Maria Tsakona, Thomas Konstantinos, Athina Savva, Dimitra Kavatha, Dimitrios Boumpas, Konstantinos Syrigos, Ioannis Xynogalas, Konstantinos Leontis, Vasileios Ntousopoulos, Vissaria Sakka, Zafeiris Sardelis, Andreas Fotiadis, Lamprini Vlassi, Chrysoula Kontogianni, Anastasia Levounets, Garyfalia Poulakou, Mina Gaga, Ronan MacLoughlin, Justin Stebbing, Nadir Arber, Anastasia Antoniadou, Sotirios Tsiodras
Publikováno v:
Respiratory Research, Vol 25, Iss 1, Pp 1-13 (2024)
Abstract Introduction EXO-CD24 are exosomes genetically manipulated to over-express Cluster of Differentiation (CD) 24. It consists of two breakthrough technologies: CD24, the drug, as a novel immunomodulator that is smarter than steroids without any
Externí odkaz:
https://doaj.org/article/24f5adc7c431420c90c68b1ab0f43b4a
Autor:
Evdoxia Kyriazopoulou, Konstantinos Leventogiannis, Georgios Tavoulareas, Efstratios Mainas, Konstantinos Toutouzas, Christos Mathas, Athanassios Prekates, Vissaria Sakka, Periklis Panagopoulos, Konstantinos Syrigos, Evangelos J. Giamarellos-Bourboulis
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract We aimed to develop presepsin as a marker of diagnosis of severe infections of either bacterial and viral origin. The derivation cohort was recruited from 173 hospitalized patients with acute pancreatitis or post-operative fever or infection
Externí odkaz:
https://doaj.org/article/e3d248aebddb4c71bbccbfec03b59597
Autor:
Karolina Akinosoglou, Antigone Kotsaki, Ioanna-Maria Gounaridi, Eirini Christaki, Simeon Metallidis, Georgios Adamis, Archontoula Fragkou, Massimo Fantoni, Aggeliki Rapti, Ioannis Kalomenidis, Georgios Chrysos, Gloria Boni, Ilias Kainis, Zoi Alexiou, Francesco Castelli, Francesco Saverio Serino, Petros Bakakos, Emanuele Nicastri, Vassiliki Tzavara, Asimina Safarika, Sofia Ioannou, Lorenzo Dagna, Katerina Dimakou, Glykeria Tzatzagou, Maria Chini, Matteo Bassetti, Vasileios Kotsis, Andrea Angheben, George Tsoukalas, Carlo Selmi, Olga-Maria Spiropoulou, Michael Samarkos, Michael Doumas, Georgia Damoraki, Aikaterini Masgala, Ilias Papanikolaou, Aikaterini Argyraki, Marcantonio Negri, Konstantinos Leventogiannis, Styliani Sympardi, Nikolaos K. Gatselis, Vasileios Petrakis, Mihai G. Netea, Periklis Panagopoulos, Vissaria Sakka, Haralampos Milionis, George N. Dalekos, Evangelos J. Giamarellos-Bourboulis
Publikováno v:
EClinicalMedicine, Vol 56, Iss , Pp 101785- (2023)
Summary: Background: The SAVE-MORE trial demonstrated that anakinra treatment in COVID-19 pneumonia with plasma soluble urokinase plasminogen activator (suPAR) levels of 6 ng/mL or more was associated with 0.36 odds for a worse outcome compared to pl
Externí odkaz:
https://doaj.org/article/849b622a96a44a189757b8aa960d5cf4
Autor:
Maria Drogari-Apiranthitou, Anna Skiada, Ioannis Panayiotides, Timoleon-Achilleas Vyzantiadis, Aikaterina Poulopoulou, Myrto Christofidou, Anastasia Antoniadou, Emmanuel Roilides, Elias Iosifidis, Vassiliki Mamali, Athina Argyropoulou, Styliani Sympardi, Nikoletta Charalampaki, Nikolaos Antonakos, Paraskevi Mantzana, Zafeiria Mastora, Ourania Nicolatou-Galitis, Maria Orfanidou, Zoi-Dorothea Pana, Ioannis Pavleas, Angelos Pefanis, Vissaria Sakka, Anastasia Spiliopoulou, Maria Stamouli, Polydoros Tofas, Eleni Vagiakou, George Petrikkos
Publikováno v:
Journal of Fungi, Vol 9, Iss 4, p 425 (2023)
Mucormycosis has emerged as a group of severe infections mainly in immunocompromised patients. We analysed the epidemiology of mucormycosis in Greece in a multicentre, nationwide prospective survey of patients of all ages, during 2005–2022. A total
Externí odkaz:
https://doaj.org/article/765f8f54c9954e48bc68dfdf6e8a39fd
Autor:
Ioannis P. Trontzas, Ioannis Vathiotis, Christina Economidou, Ioulia Petridou, Georgia Gomatou, Maria Grammoustianou, Ioannis Tsamis, Nikolaos Syrigos, Maximilian Anagnostakis, Eleni Fyta, Vissaria Sakka, Garyphalia Poulakou, Elias A. Kotteas, Ekaterini Syrigou
Publikováno v:
Vaccines, Vol 10, Iss 4, p 618 (2022)
Background: SARS-CoV-2 mortality rates are significantly higher in patients with lung cancer compared with the general population. However, little is known on their immunization status after vaccination. Methods: To evaluate the humoral response (ser
Externí odkaz:
https://doaj.org/article/c64cfe071700492aa384b7199708a47d
Autor:
Konstantinos Kontoangelos, Sofia Tsiori, Garyfalia Poulakou, Konstantinos Protopapas, Ioannis Katsarolis, Vissaria Sakka, Dimitra Kavatha, Antonios Papadopoulos, Anastasia Antoniadou, Charalambos C. Papageorgiou
Publikováno v:
Mental Illness, Vol 9, Iss 1 (2017)
The Greek version of the Davidson Trauma Scale (DTS) was developed to respond to the need of Greek-speaking individuals. The translated questionnaire was administered to 128 HIV outpatients (aged 37.1±9.1) and 166 control patients (aged 32.4±13.4).
Externí odkaz:
https://doaj.org/article/4c5b1eb5bd3048d5a0b21fbab92ffc7e
Autor:
Evangelos J Giamarellos-Bourboulis, Maria Raftogiannis, Anastasia Antonopoulou, Fotini Baziaka, Pantelis Koutoukas, Athina Savva, Theodora Kanni, Marianna Georgitsi, Aikaterini Pistiki, Thomas Tsaganos, Nikolaos Pelekanos, Sofia Athanassia, Labrini Galani, Efthymia Giannitsioti, Dimitra Kavatha, Flora Kontopidou, Maria Mouktaroudi, Garyfallia Poulakou, Vissaria Sakka, Periklis Panagopoulos, Antonios Papadopoulos, Kyriaki Kanellakopoulou, Helen Giamarellou
Publikováno v:
PLoS ONE, Vol 4, Iss 12, p e8393 (2009)
BackgroundThe pandemic by the novel H1N1 virus has created the need to study any probable effects of that infection in the immune system of the host.Methodology/principal findingsBlood was sampled within the first two days of the presentation of sign
Externí odkaz:
https://doaj.org/article/72dc877a2b4f4d70acc3e048f85057b9
Autor:
Eleni Kortianou, Dimitrios Tsimouris, Aspasia Mavronasou, Sotirios Lekkas, Nikolaos Kazatzis, Zoi Apostolara, Maria Isakoglou, Georgia Dimakou, Zafeiria Barmparessou, Stamatoula Tsikrika, Vissaria Sakka, Angelos Liontos, Maria Christaki, Haralampos Milionis, Ioannis Kalomenidis
Publikováno v:
Pneumon. 35:1-10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::995b9168b8b57a8836a1ac79db4d223c
https://doi.org/10.18332/pne/146521
https://doi.org/10.18332/pne/146521
Autor:
Ioannis Grigoropoulos, Georgios Tsioulos, Artemis Kastrissianakis, Shiran Shapira, Nadir Arber, Garyfallia Poulakou, Konstantinos Syrigos, Vasiliki Rapti, Ioannis Xynogalas, Konstantinos Leontis, Vasileios Ntousopoulos, Vissaria Sakka, Mina Gaga, Zafeiris Sardelis, Andreas Fotiadis, Lamprini Vlassi, Chrysoula Kontogianni, Anastasia Levounets, Maria Tsakona, Athina Savva, Dimitra Kavatha, Dimitrios Boumpas, Anastasia Antoniadou, Sotirios Tsiodras
Publikováno v:
Open Forum Infectious Diseases. 9
Background EXO-CD24 is a novel inhaled drug of exosomes displaying CD24, a protein with anti-inflammatory properties. We evaluated the safety and potential efficacy of EXO-CD24, in a phase II, randomized, single-blinded clinical trial of EXO-CD24 in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18d967e4befa8a8f9d4cf7b1907fa704
https://doi.org/10.1093/ofid/ofac492.991
https://doi.org/10.1093/ofid/ofac492.991
Autor:
Karolina Akinosoglou, Antigone Kotsaki, Ioanna-Maria Gounaridi, Eirini Christaki, Simeon Metallidis, Georgios Adamis, Archontoula Fragkou, Massimo Fantoni, Aggeliki Rapti, Ioannis Kalomenidis, Georgios Chrysos, Gloria Boni, Ilias Kainis, Zoi Alexiou, Francesco Castelli, Francesco Saverio Serino, Petros Bakakos, Emanuele Nicastri, Vassiliki Tzavara, Asimina Safarika, Sofia Ioannou, Lorenzo Dagna, Katerina Dimakou, Glykeria Tzatzagou, Maria Chini, Matteo Bassetti, Vasileios Kotsis, Andrea Angheben, George Tsoukalas, Carlo Selmi, Olga-Maria Spiropoulou, Michael Samarkos, Michael Doumas, Georgia Damoraki, Aikaterini Masgala, Ilias Papanikolaou, Aikaterini Argyraki, Marcantonio Negri, Konstantinos Leventogiannis, Styliani Sympardi, Nikolaos K. Gatselis, Vasileios Petrakis, Mihai G. Netea, Periklis Panagopoulos, Vissaria Sakka, Haralampos Milionis, George N. Dalekos, Evangelos J. Giamarellos-Bourboulis
Publikováno v:
EClinicalMedicine. 56
The SAVE-MORE trial demonstrated that anakinra treatment in COVID-19 pneumonia with plasma soluble urokinase plasminogen activator (suPAR) levels of 6 ng/mL or more was associated with 0.36 odds for a worse outcome compared to placebo when expressed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a96f3a90364b2bdf051c028740bd055
https://pubmed.ncbi.nlm.nih.gov/36590789
https://pubmed.ncbi.nlm.nih.gov/36590789